表紙
市場調查報告書
商品編碼
1076653

被忽視的熱帶病(NTD)診斷全球市場:市場規模,份額,趨勢分析,疾病(登革熱,基孔肯雅熱),診斷方法(常規,分子/最新),服務類型,最終用戶,細部預測2022-2030

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End-use, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research, Inc. | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球被忽視熱帶病(NTD)診斷市場預計到2030年將保持4.4%的複合年增長率,達到新台幣89.7億元。

市場增長的主要驅動力是疾病負擔的增加、對疾病早期檢測的需求增加、技術的互補性進步以及對經濟影響的日益關注。

本報告探討了全球被忽視的熱帶病 (NTD) 診斷市場,包括市場概況、市場規模和預測、趨勢、增長因素和挑戰、客戶狀況、疾病、診斷方法和服務。提供類型、最終用戶、區域分析和競爭條件。

目錄

第 1 章調查方法及範圍

第 2 章執行摘要

第 3 章被忽視的熱帶病 (NTD) 診斷市場變量、趨勢和範圍

  • 市場體系展望
  • 滲透率和增長前景映射
  • 用戶視角分析
  • 市場動態
  • 被忽視的熱帶病 (NTD) 診斷:市場分析工具

第 4 章被忽視的熱帶病 (NTD) 診斷市場:細分分析,特定疾病 (2017-2030)

  • 定義和範圍
  • 按疾病分類的市場份額分析(2021-2030 年)
  • 全球被忽視的熱帶病 (NTD) 診斷市場,按疾病分類 (2017-2030)
  • 市場規模及預測及趨勢分析(2017-2030)
    • 登革熱
    • 基孔肯雅熱
    • 狂犬病
    • 漢森氏病
    • 布魯裡潰瘍
    • 偏航
    • 淋巴絲蟲病
    • 絛蟲病/囊尾蚴病
    • 食物中毒吸蟲感染
    • 棘球蚴
    • 南美錐蟲病
    • 麥地那龍線蟲病
    • 人類非洲錐蟲病(昏睡病)
    • 土傳蠕蟲病
    • 盤尾絲蟲病
    • 血吸蟲病
    • 疥瘡和其他體外寄生蟲
    • 蛇咬毒
    • 利甚曼病

第 5 章被忽視的熱帶病 (NTD) 診斷市場:細分分析,按診斷方法 (2017-2030)

  • 定義和範圍
  • 診斷方法的市場份額分析(2021 年和 2030 年)
  • 全球被忽視的熱帶病 (NTD) 診斷市場,按診斷方法分類 (2017-2030)
  • 市場規模及預測及趨勢分析(2017-2030)
    • 常規類型
    • 分子/最新類型

第 6 章被忽視的熱帶病 (NTD) 診斷市場:細分分析,按服務類型 (2017-2030)

  • 定義和範圍
  • 按服務類型劃分的市場份額分析(2021 年和 2030 年)
  • 全球被忽視的熱帶病 (NTD) 診斷市場,按服務類型 (2017-2030)
  • 市場規模及預測及趨勢分析(2017-2030)
    • 集中式服務
    • POC 服務

第 7 章被忽視的熱帶病 (NTD) 診斷市場:細分分析,最終用戶(2017-2030)

  • 定義和範圍
  • 最終用戶的市場份額分析(2021 年和 2030 年)
  • 全球被忽視的熱帶病 (NTD) 診斷市場,按服務類型 (2017-2030)
  • 市場規模及預測及趨勢分析(2017-2030)
    • 臨床實驗室
    • 醫院/診所
    • 家庭保健

第 8 章被忽視的熱帶病 (NTD) 診斷市場:區域市場分析,按區域 (2017-2030)

  • 定義和範圍
  • 區域市場份額分析(2021 年和 2030 年)
  • 區域市場儀表板
  • 區域市場:主要公司
  • 市場規模、預測和趨勢分析(2021-2030 年)
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
  • 亞太地區
    • 中國
    • 印度尼西亞
    • 印度
    • 馬來西亞
  • 拉丁美洲
    • 巴西
    • 哥倫比亞
    • 委內瑞拉
  • 中東和非洲
    • 尼日利亞

第 9 章被忽視的熱帶病 (NTD) 診斷市場:競爭分析

  • 企業/競爭分類(主要創新者、市場領導者、初創企業)
  • 供應商情況
    • 主要經銷商和渠道合作夥伴名單
  • 主要公司簡介
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix
    • InBios International、Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • Oscar Medicare Pvt Ltd.
目錄
Product Code: GVR-2-68038-319-5

Neglected Tropical Diseases Diagnosis Market Growth & Trends:

The global neglected tropical disease (NTD) diagnostic market size is expected to reach USD 8.97 billion by 2030, expanding at a CAGR of 4.4% during the forecast period, according to a new report by Grand View Research, Inc. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Disease Diagnosis Market Report Highlights:

  • By disease type, the soil-transmitted helminthiases dominated the market in 2021, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2021, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2021 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2021, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Information procurement
    • 1.2.1 Purchased database
    • 1.2.2 GVR's internal database
    • 1.2.3 Secondary sources & third-party perspectives
    • 1.2.4 Primary research
  • 1.3 Information analysis
    • 1.3.1 Data analysis models
  • 1.4 Market formulation & data visualization
  • 1.5 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Neglected Tropical Diseases Diagnosis Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 User perspective analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
    • 3.4.2 Market Restraint Analysis
    • 3.4.3 Industry Challenges
  • 3.5 Neglected Tropical Diseases Diagnosis: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
      • 3.5.1.1 Supplier Power
      • 3.5.1.2 Buyer Power
      • 3.5.1.3 Substitution Threat
      • 3.5.1.4 Threat from new entrant
      • 3.5.1.5 Competitive rivalry
    • 3.5.2 PESTEL Analysis
      • 3.5.2.1 Political Landscape
      • 3.5.2.2 Environmental Landscape
      • 3.5.2.3 Social Landscape
      • 3.5.2.4 Technology Landscape
      • 3.5.2.5 Legal Landscape

Chapter 4 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Disease, 2017 - 2030 (USD Million)

  • 4.1 Definitions & Scope
  • 4.2 Disease market share analysis, 2021 - 2030
  • 4.3 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 to 2030
  • 4.4 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 4.4.1 Dengue
    • 4.4.2 Chikungunya
    • 4.4.3 Rabies
    • 4.4.4 Leprosy
    • 4.4.5 Buruli ulcer
    • 4.4.6 Yaws
    • 4.4.7 Lymphatic Filariasis
    • 4.4.8 Taeniasis/Cysticercosis
    • 4.4.9 Foodborne trematode infections
    • 4.4.10 Echinococcosis
    • 4.4.11 Chagas disease
    • 4.4.12 Dracunculiasis
    • 4.4.13 Human African trypanosomiasis (sleeping sickness)
    • 4.4.14 Soil-transmitted helminthiases
    • 4.4.15 Onchocerciasis
    • 4.4.16 Schistosomiasis
    • 4.4.17 Scabies and other ectoparasites
    • 4.4.18 Snakebite Envenoming
    • 4.4.19 Leishmaniases

Chapter 5 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Diagnostic Method, 2027 - 2030 (USD Million)

  • 5.1 Definitions & Scope
  • 5.2 Diagnostic method market share analysis, 2021 & 2030
  • 5.3 Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic method, 2017 to 2030
  • 5.4 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 5.4.1 Conventional Method
    • 5.4.2 Molecular/Modern Method

Chapter 6 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Service Type, 2017 - 2030 (USD Million)

  • 6.1 Definitions & Scope
  • 6.2 Service type market share analysis, 2021 & 2030
  • 6.3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 to 2030
  • 6.4 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 6.4.1 Centralized Service
    • 6.4.2 POC Service

Chapter 7 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By End Use, 2017 - 2030 (USD Million)

  • 7.1 Definitions & Scope
  • 7.2 End-use market share analysis, 2021 & 2030
  • 7.3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 to 2030
  • 7.4 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 7.4.1 Clinical Labs
    • 7.4.2 Hospitals /Clinics
    • 7.4.3 Home Healthcare

Chapter 8 Neglected Tropical Diseases Diagnosis Market: Regional Market Analysis, By Region, 2017 - 2030 (USD Million)

  • 8.1 Definitions & Scope
  • 8.2 Regional market share analysis, 2021 & 2030
  • 8.3 Regional Market Dashboard
  • 8.4 Regional Market: Key Players
  • 8.5 Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
  • 8.6 North America
    • 8.6.1 North America market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.6.2 U.S.
      • 8.6.2.1 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.6.3 Canada
      • 8.6.3.1 Canada market estimates and forecast, 2017 - 2030 (USD Million)
  • 8.7 Europe
    • 8.7.1 Europe market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.7.2 Germany
      • 8.7.2.1 Germany market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.7.3 UK
      • 8.7.3.1 UK market estimates and forecast, 2017 - 2030 (USD Million)
  • 8.8 Asia Pacific
    • 8.8.1 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.8.2 China
      • 8.8.2.1 China market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.8.3 Indonesia
      • 8.8.3.1 Indonesia market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.8.4 India
      • 8.8.4.1 India market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.8.5 Malaysia
      • 8.8.5.1 Malaysia market estimates and forecast, 2017 - 2030 (USD Million)
  • 8.9 Latin America
    • 8.9.1 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.9.2 Brazil
      • 8.9.2.1 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.9.3 Colombia
      • 8.9.3.1 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.9.4 Venezuela
      • 8.9.4.1 Venezuela market estimates and forecast, 2017 - 2030 (USD Million)
  • 8.10 Middle East and Africa
    • 8.10.1 Middle East and Africa market estimates and forecast, 2017 - 2030 (USD Million)
    • 8.10.2 Nigeria
      • 8.10.2.1 Nigeria market estimates and forecast, 2017 - 2030 (USD Million)

Chapter 9 Neglected Tropical Diseases Diagnosis Market - Competitive Analysis

  • 9.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 9.2 Vendor Landscape
    • 9.2.1 List of key distributors and channel partners
  • 9.3 Key companies profiled
    • 9.3.1 F. Hoffmann-La Roche Ltd
      • 9.3.1.1 Company Overview
      • 9.3.1.2 Financial Performance
      • 9.3.1.3 Product Benchmarking
      • 9.3.1.4 Strategic Initiatives
    • 9.3.2 Abbott
      • 9.3.2.1 Company Overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product Benchmarking
      • 9.3.2.4 Strategic Initiatives
    • 9.3.3 Thermo Fisher Scientific Inc.
      • 9.3.3.1 Company Overview
      • 9.3.3.2 Financial Performance
      • 9.3.3.3 Product Benchmarking
      • 9.3.3.4 Strategic Initiatives
    • 9.3.4 ZeptoMetrix
      • 9.3.4.1 Company Overview
      • 9.3.4.2 Financial Performance
      • 9.3.4.3 Product Benchmarking
      • 9.3.4.4 Strategic Initiatives
    • 9.3.5 InBios International, Inc.
      • 9.3.5.1 Company Overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product Benchmarking
      • 9.3.5.4 Strategic Initiatives
    • 9.3.6 Genome Diagnostics Pvt. Ltd.
      • 9.3.6.1 Company Overview
      • 9.3.6.2 Financial Performance
      • 9.3.6.3 Product Benchmarking
      • 9.3.6.4 Strategic Initiatives
    • 9.3.7 Omega Diagnostics Group PLC
      • 9.3.7.1 Company Overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product Benchmarking
      • 9.3.7.4 Strategic Initiatives
    • 9.3.8 Coris BioConcept
      • 9.3.8.1 Company Overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product Benchmarking
      • 9.3.8.4 Strategic Initiatives
    • 9.3.9 DiaSys Diagnostic Systems GmbH
      • 9.3.9.1 Company Overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product Benchmarking
      • 9.3.9.4 Strategic Initiatives
    • 9.3.10 Oscar Medicare Pvt Ltd.
      • 9.3.10.1 Company Overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product Benchmarking
      • 9.3.10.4 Strategic Initiatives

List of Tables

  • Table 1 Global Neglected Tropical Diseases Diagnosis Market, By Region, 2017 - 2030 (USD Million)
  • Table 2 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 4 Global Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 5 North America Neglected Tropical Diseases Diagnosis Market, By Region, 2017 - 2030 (USD Million)
  • Table 6 North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 7 North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 8 North America Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 9 U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 10 U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 11 U.S. Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 12 Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 13 Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 14 Canada Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 15 Europe Neglected Tropical Diseases Diagnosis Market, By Region, 2017 - 2030 (USD Million)
  • Table 16 Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 17 Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 18 Europe Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 19 UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 20 UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 21 UK Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 22 Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 23 Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 24 Germany Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 25 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Region, 2017 - 2030 (USD Million)
  • Table 26 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 27 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 28 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 29 Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 30 Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 31 Indonesia Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 32 China Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 33 China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 34 China Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 35 India Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 36 India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 37 India Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 38 Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 39 Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 40 Malaysia Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 41 Latin America Neglected Tropical Diseases Diagnosis Market, By Region, 2017 - 2030 (USD Million)
  • Table 42 Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 43 Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 44 Latin America Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 45 Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 46 Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 47 Brazil Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 48 Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 49 Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 50 Colombia Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 51 Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 52 Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 53 Venezuela Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 54 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Region, 2017 - 2030 (USD Million)
  • Table 55 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 56 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 57 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)
  • Table 58 Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2017 - 2030 (USD Million)
  • Table 59 Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2017 - 2030 (USD Million)
  • Table 60 Nigeria Neglected Tropical Diseases Diagnosis Market, By End-use, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Neglected Tropical Diseases Diagnosis market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Neglected tropical diseases diagnosis market: Disease movement analysis
  • Fig. 16 Neglected tropical diseases diagnosis market: Diagnostic method movement analysis
  • Fig. 17 Neglected tropical diseases diagnosis market: Service type movement analysis
  • Fig. 18 Neglected tropical diseases diagnosis market: End-use movement analysis
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 Regional outlook, 2017 & 2030
  • Fig. 21 North America Neglected Tropical Diseases Diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 22 U.S. neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 23 Canada neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 24 Europe neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 25 UK neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 26 Germany neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 27 Asia Pacific neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 28 Indonesia neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 29 China neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 30 India neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 31 Malaysia neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 32 Latin America neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 33 Brazil neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 34 Colombia neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 35 Venezuela neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 36 MEA neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)
  • Fig. 37 Nigeria neglected tropical diseases diagnosis market, 2017 - 2030 (USD Million)